{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:18Z","timestamp":1762867878025,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.endien.2022.11.014","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:14:55Z","timestamp":1668446095000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors"],"prefix":"10.1016","volume":"70","author":[{"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2022.11.014_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.endien.2022.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2006.12.001","article-title":"Molecular genetics of neuroendocrine tumors","volume":"21","author":"Duerr","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.11.014_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ACI.0000000000000406","article-title":"Inherited and acquired clinical phenotypes associated with neuroendocrine tumors","volume":"17","author":"Nicholaides","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"10.1016\/j.endien.2022.11.014_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MED.0b013e328320d845","article-title":"Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors)","volume":"16","author":"\u00d6berg","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"10.1016\/j.endien.2022.11.014_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.endien.2022.11.014_bib0030","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.endien.2022.11.014_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-18-0120","article-title":"Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms","volume":"26","author":"Vandamme","year":"2019","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00267","article-title":"Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability","volume":"2018","author":"Raj","year":"2018","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.endien.2022.11.014_bib0045","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology Policy Statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endien.2022.11.014_bib0050","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s00428-007-0450-3","article-title":"Hereditary neuroendocrine tumors of the gastroenteropancreatic system","volume":"451","author":"Anlauf","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.endien.2022.11.014_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2018.03.018","article-title":"Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3","volume":"77","author":"Konukiewitz","year":"2018","journal-title":"Hum Pathol."},{"key":"10.1016\/j.endien.2022.11.014_bib0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"key":"10.1016\/j.endien.2022.11.014_bib0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1677\/ERC-10-0028","article-title":"MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases","volume":"17","author":"Corbo","year":"2010","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2002.01589.x","article-title":"Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil","volume":"57","author":"Kaltsas","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.11.014_bib0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms","volume":"40","author":"Mafficini","year":"2019","journal-title":"Endocr Rev."},{"key":"10.1016\/j.endien.2022.11.014_bib0080","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet."},{"key":"10.1016\/j.endien.2022.11.014_bib0085","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gutjnl-2020-321300","article-title":"Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?","volume":"70","author":"Rinke","year":"2021","journal-title":"Gut."},{"key":"10.1016\/j.endien.2022.11.014_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jso.20111","article-title":"FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor","volume":"87","author":"Camp","year":"2004","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.endien.2022.11.014_bib0095","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1530\/ERC-17-0012","article-title":"Genetic and epigenetic drivers of neuroendocrine tumours (NET)","volume":"24","author":"Di Domenico","year":"2017","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.endien.2022.11.014_bib0105","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","article-title":"ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup","volume":"9","author":"Chan","year":"2018","journal-title":"Nat Commun."},{"key":"10.1016\/j.endien.2022.11.014_bib0110","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.bjc.6603419","article-title":"A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas","volume":"95","author":"Duran","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.575620","article-title":"Molecular signatures and their clinical utility in pancreatic neuroendocrine tumors","volume":"11","author":"Chatani","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.endien.2022.11.014_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.advms.2019.10.002","article-title":"The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors","volume":"65","author":"Malczewska","year":"2020","journal-title":"Adv Med Sci."},{"key":"10.1016\/j.endien.2022.11.014_bib0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-015-3250-z","article-title":"Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors","volume":"43","author":"Bodei","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.endien.2022.11.014_bib0130","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.11.014_bib0135","first-page":"56","article-title":"Clinical and genetic aspects of phaeochromocytoma","volume":"59","author":"Opocher","year":"2003","journal-title":"Horm Res."},{"key":"10.1016\/j.endien.2022.11.014_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084041","article-title":"Pancreatic neuroendocrine neoplasms in multiple endocrine neoplasia type 1","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.endien.2022.11.014_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MPA.0000000000000825","article-title":"Treatment of pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 some clarity but continued controversy","volume":"46","author":"Jensen","year":"2017","journal-title":"Pancreas."},{"key":"10.1016\/j.endien.2022.11.014_bib0150","first-page":"212","article-title":"Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution","volume":"163","author":"Christakis","year":"2018","journal-title":"Surg (United States)."},{"key":"10.1016\/j.endien.2022.11.014_bib0155","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5009\/gnl.2012.6.3.287","article-title":"The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1","volume":"6","author":"Niina","year":"2012","journal-title":"Gut Liver."},{"key":"10.1016\/j.endien.2022.11.014_bib0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2005-1349","article-title":"Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett\u2019s esophagus","volume":"91","author":"Hoffmann","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.11.014_bib0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0000000000000110","article-title":"A systematic review of localization, surgical treatment options, and outcome of insulinoma","volume":"43","author":"Mehrabi","year":"2014","journal-title":"Pancreas."},{"key":"10.1016\/j.endien.2022.11.014_bib0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-14-0878","article-title":"Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d\u2019\u00e9tude des Tumeurs Endocrines (GTE) retrospective study","volume":"172","author":"Vezzosi","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2022.11.014_bib0180","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.endien.2022.11.014_bib0185","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0190","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"Von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.endien.2022.11.014_bib0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/erc.1.00683","article-title":"Von Hippel-Lindau disease and endocrine tumour susceptibility","volume":"13","author":"Woodward","year":"2006","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0200","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery."},{"key":"10.1016\/j.endien.2022.11.014_bib0205","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","article-title":"Long-term prognosis of resected pancreatic neuroendocrine tumors in von hippel-lindau disease is favorable and not influenced by small tumors left in place","volume":"262","author":"De Mestier","year":"2015","journal-title":"Ann Surg."},{"key":"10.1016\/j.endien.2022.11.014_bib0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association","volume":"14","author":"Roach","year":"1999","journal-title":"J Child Neurol."},{"key":"10.1016\/j.endien.2022.11.014_bib0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","article-title":"Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex","volume":"82","author":"Larson","year":"2012","journal-title":"Clin Genet."},{"key":"10.1016\/j.endien.2022.11.014_bib0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.endien.2022.11.014_bib0225","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly","year":"2019","journal-title":"Med Clin North Am."},{"key":"10.1016\/j.endien.2022.11.014_bib0230","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11605-009-1123-0","article-title":"Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases","volume":"14","author":"Relles","year":"2010","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.endien.2022.11.014_bib0235","doi-asserted-by":"crossref","first-page":"i124","DOI":"10.1093\/noajnl\/vdaa032","article-title":"Abdominal neoplastic manifestations of neurofibromatosis type 1","volume":"2","author":"Dare","year":"2020","journal-title":"Neuro-Oncology Adv."},{"key":"10.1016\/j.endien.2022.11.014_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.endien.2022.11.014_bib0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.33978","article-title":"Management recommendations for pancreatic manifestations of von Hippel-Lindau disease","volume":"128","author":"Laks","year":"2022","journal-title":"Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J Pathol."},{"key":"10.1016\/j.endien.2022.11.014_bib0255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/1471-2407-8-388","article-title":"Histone H1x is highly expressed in human neuroendocrine cells and tumours","volume":"8","author":"Warneboldt","year":"2008","journal-title":"BMC Cancer."},{"issue":"4","key":"10.1016\/j.endien.2022.11.014_bib0260","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/erc.0.0100437","article-title":"Genetics of neuroendocrine and carcinoid tumours","volume":"10","author":"Leotlela","year":"2003","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0265","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cancers14030520","article-title":"Bronchial carcinoids: from molecular background to treatment approach","volume":"14","author":"Araujo-Castro","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.endien.2022.11.014_bib0270","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1210\/jc.2013-2782","article-title":"MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids","volume":"99","author":"Swarts","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.11.014_bib0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.endien.2022.11.014_bib0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3892\/or.2012.2017","article-title":"Phosphatidylinositol-3-kinase \u03b1 catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours","volume":"28","author":"Capodanno","year":"2012","journal-title":"Oncol Rep."},{"key":"10.1016\/j.endien.2022.11.014_bib0285","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/ERC-13-0042","article-title":"MTOR, p70S6K, AKT, and ERK1\/2 levels predict sensitivity to mTOR and PI3K\/mTOR inhibitors in human bronchial carcinoids","volume":"20","author":"Gagliano","year":"2013","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0290","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1677\/ERC-10-0097","article-title":"Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids","volume":"17","author":"Zatelli","year":"2010","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0295","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/ERC-13-0482","article-title":"Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis","volume":"21","author":"Pieterman","year":"2014","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000435921","article-title":"Bronchopulmonary neuroendocrine neoplasms and their precursor lesions in multiple endocrine neoplasia type 1","volume":"103","author":"Bartsch","year":"2016","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.endien.2022.11.014_bib0305","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.semcancer.2021.04.011","article-title":"Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)","volume":"79","author":"Effraimidis","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.endien.2022.11.014_bib0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00268-017-4135-z","article-title":"Histologically proven bronchial neuroendocrine tumors in MEN1: a GTE 51-case cohort study","volume":"42","author":"Lecomte","year":"2018","journal-title":"World J Surg."},{"key":"10.1016\/j.endien.2022.11.014_bib0315","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"De Laat","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.11.014_bib0320","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/1097-0142(20010601)91:11<2104::AID-CNCR1238>3.0.CO;2-I","article-title":"Familial pulmonary carcinoid tumors","volume":"91","author":"Oliveira","year":"2001","journal-title":"Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0325","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cllc.2020.11.010","article-title":"Mutation profile of thymic carcinoma and thymic neuroendocrine tumor by targeted next-generation sequencing","volume":"22","author":"Sakane","year":"2021","journal-title":"Clin Lung Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0330","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1677\/ERC-08-0325","article-title":"Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism","volume":"16","author":"Bi","year":"2009","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2017.05.019","article-title":"Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours","volume":"111","author":"Kajiura","year":"2017","journal-title":"Lung Cancer."},{"key":"10.1016\/j.endien.2022.11.014_bib0340","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cen.13480","article-title":"Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis","volume":"87","author":"Ye","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.11.014_bib0345","first-page":"135","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 men1\/zollinger-ellison syndrome patients with 1613 literature men1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Med (United States)."},{"key":"10.1016\/j.endien.2022.11.014_bib0350","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12020-021-02636-x","article-title":"Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes","volume":"71","author":"Butz","year":"2021","journal-title":"Endocrine."},{"key":"10.1016\/j.endien.2022.11.014_bib0355","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg3493","article-title":"Molecular genetic testing and the future of clinical genomics","volume":"14","author":"Katsanis","year":"2013","journal-title":"Nat Rev Genet."},{"key":"10.1016\/j.endien.2022.11.014_bib0360","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:14Z","timestamp":1762867094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018022001780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":72,"alternative-id":["S2530018022001780"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2022.11.014","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2022.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2022.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}